DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20162428

Knowledge, attitude and practice study regarding pharmacovigilance programme of India among private practitioners in urban Odisha, India

Trupti Rekha Swain, Neha Nityadarshini, Suchismita Pattnaik, Kali Prasanna Swain

Abstract


Background: Private health care providers play an important role in health programmes of a country. Pharmacovigilance programme of India (PVPI) seeks involvement of different health sectors to make it successful. Knowledge, attitude and practice (KAP) studies provide a base line information about human behaviour and practices so that a properly planned acceptable intervention can be made.

Methods: level of knowledge, attitude and practice regarding pharmacovigilance programme of India was evaluated among doctors working in private hospitals/clinics of Bhubaneswar and Cuttack city of Odisha. A thirty three item questionnaire was used to collect the data which contained 12 knowledge, 12 attitude and 9 practice based questions.

Results: Only fifty four out of 124 participating doctors responded positively. The knowledge level of practitioners was found to be acceptable with 38.9% subjects scoring more than 70%. However a gap in knowledge was observed regarding some specific area and was not translated in terms of good quality reporting of ADRs. Only 13 (24.1%) practitioners were found to have actually reported ADR to Pharmacovigilance centre.

Conclusions: Adequate awareness should be created among private practioners regarding the pharmacovigilance programme of India. Easy accessibility of ADR forms and appropriate educational intervention through media can improve ADR reporting.


Keywords


PVPI, ADRs, KAP, Pharmacovigilance

Full Text:

PDF

References


Rishi RK, Patel RK, Bhandari A. Under reporting of ADRs by medical practitioners in India - results of pilot study. Adv Pharmacoepidem Drug Safety. 2012;1:112.

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital-their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12(8):687-92.

Davis EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLos ONE. 2009;4:e4439.

Healthcare in India. Wikimedia Foundation, Inc. Available at http://en.wikipedia.org/wiki/ Healthcare_in_India#Public_and_private_sector.

Gupta M. Working paper no. 89 state health systems: Orissa. Indian council for research on international economic relations; 2002. Available at http://www.icrier.org/pdf/WP__89.pdf.

The Importance of Pharmacovigilance, WHO, 2002. Available at http://apps.who.int/medicinedocs/ pdf/s4893e/s4893e.pdf.

Pimpalkhute SA, Jaiswal KM, Sontakke SD, Bajait CS, Gaikwad A. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci. 2012;66(3-4):55-61.

Subish P, Izham M, Mishra P. Evaluation of the knowledge, attitude and practices on adverse drug reactions and pharmacovigilance among healthcare professionals in a Nepalese hospital: a preliminary study. The Internet Journal of Pharmacology. 2007;6(1).

Lopez‑Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under‑reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19‑31.

Smith CC, Bennet PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reaction in a hospital general medical Unit meriting notification to the committee on safety of medicines. Br J Clin Pharmacol. 1996;42:423‑42.

Feely J, Moriarty S, O’Connor P. Stimulating reporting of adverse drug reaction by using a fee. Br Med J. 1990;300:22‑3.

Inman WH. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41:433‑5.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: knowledge, attitudes and perceptions amongst resident doctors. J Pharm Sci Res. 2011;3:1064‑9.

Kharkar M, Bowalekar S. Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. 2012;3(3):90-4.

Agarwal R, Daher AM, Ismail NM. Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from Klang valley in Malaysia. Malays J Med Sci. 2013;20(2):52-61.

Belton KL, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223-6.

Desai CK, Iyer G, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2(4):129-39.

Praveen S, Prakash JR, Manjunath GN, Gautham MS, Kumar N. Adverse drug reaction reporting among medical and dental practitioners: a KAP study. IJMS. 2013;4(1):10-5.

Dang A, Rataboli PV. Adverse drug reaction (ADR) notification drop box: an easy way to report ADRs. Br J Clin Pharmacol. 2008;66(5):723-4.